Multidisciplinary Cancer Investigation
Tue, Jul 16, 2024
[Archive]
Volume 7, Issue 3 (Multidisciplinary Cancer Investigation 2023)
Multidiscip Cancer Investig 2023, 7(3): 21-27 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Abdollahi Boraei S B, Pirkani Z, Nourmohammadi J, Abdollahi Boraei B, Dehghan M M, Rahmanian M. Control of Bone Metastasis Caused by Breast Cancer Using Nanocomposite Scaffolds Containing Strontium Ranelate. Multidiscip Cancer Investig 2023; 7 (3) :21-27
URL: http://mcijournal.com/article-1-389-en.html
URL: http://mcijournal.com/article-1-389-en.html
Seyyed Behnam Abdollahi Boraei 
1, Zanyar Pirkani2 , J.Jhamak Nourmohammadi3 , Behnaz Abdollahi Boraei4 , Mohammad Mehdi Dehghan5 , Mehdi Rahmanian6
1, Zanyar Pirkani2 , J.Jhamak Nourmohammadi3 , Behnaz Abdollahi Boraei4 , Mohammad Mehdi Dehghan5 , Mehdi Rahmanian6
1- Biomaterials and Tissue Engineering Research Group, Department of Interdisciplinary Technologies, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran , be.abdollahi@ut.ac.ir
2- Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
3- Faculty of Life Science Engineering, Faculties of Sciences and Interdisciplinary Technologies, University of Tehran, Tehran, Iran
4- Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran
5- Department of Surgery and Radiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
6- Biomaterials and Tissue Engineering Research Group, Department of Interdisciplinary Technologies, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
2- Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
3- Faculty of Life Science Engineering, Faculties of Sciences and Interdisciplinary Technologies, University of Tehran, Tehran, Iran
4- Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran
5- Department of Surgery and Radiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
6- Biomaterials and Tissue Engineering Research Group, Department of Interdisciplinary Technologies, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
Abstract: (87 Views)
Introduction: Bone metastases are one of the most important consequences of breast cancer, and the possibility of developing them is greatly increased due to the late diagnosis of the cancer. In general, systemic treatments for metastases can have many side effects. To reduce this concern, tissue engineering scaffolds containing osteogenesis drugs can be used to minimize these problems as much as possible.
Methods: In this study, polycaprolactone/polyvinyl alcohol (PCL/PVA) composite scaffolds were prepared for use in bone tissue engineering with a weight percentage of strontium ranelate (SrR) drug (0, 5, and 20) by shell-core emulsion electrospinning method. Scaffolds prepared in this study were subjected to scanning electron microscopy (SEM), contact angle, and biodegradation analyses for morphological and structural investigation. Then, to check their biocompatibility, an MTT test was performed.
Results: The results of SEM images showed the nanostructure of the fibers. Also, the presence of interconnected pores with a suitable size was confirmed by the images. MTT results proved the non-toxicity of all prepared scaffolds by high cell viability (˃80%). According to the obtained results, the composite scaffolds containing the drug SrR have been successfully synthesized and have the desired properties for use in bone regeneration applications.
Conclusion: Controlling bone metastases due to breast cancer is an important concern. In this study, the composite scaffold containing strontium ranlate showed suitable physicochemical, biocompatibility, and osteogenesis characteristics.
Methods: In this study, polycaprolactone/polyvinyl alcohol (PCL/PVA) composite scaffolds were prepared for use in bone tissue engineering with a weight percentage of strontium ranelate (SrR) drug (0, 5, and 20) by shell-core emulsion electrospinning method. Scaffolds prepared in this study were subjected to scanning electron microscopy (SEM), contact angle, and biodegradation analyses for morphological and structural investigation. Then, to check their biocompatibility, an MTT test was performed.
Results: The results of SEM images showed the nanostructure of the fibers. Also, the presence of interconnected pores with a suitable size was confirmed by the images. MTT results proved the non-toxicity of all prepared scaffolds by high cell viability (˃80%). According to the obtained results, the composite scaffolds containing the drug SrR have been successfully synthesized and have the desired properties for use in bone regeneration applications.
Conclusion: Controlling bone metastases due to breast cancer is an important concern. In this study, the composite scaffold containing strontium ranlate showed suitable physicochemical, biocompatibility, and osteogenesis characteristics.
Select article type: Original/Research Article |
Subject:
Biomedical Engineering and Technologies
Received: 2023/05/9 | Accepted: 2023/07/26 | ePublished: 2023/07/29
Received: 2023/05/9 | Accepted: 2023/07/26 | ePublished: 2023/07/29
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
